MUM-1

What is the MUM1 test?

The MUM1 (Multiple Myeloma Oncogene 1) test is an immunohistochemistry (IHC) test used to detect MUM1 protein expression in tissue samples. It is mainly used in diagnosing lymphomas and plasma cell neoplasms.


Why is this test performed?

This test helps classify different types of lymphomas, such as diffuse large B-cell lymphoma (DLBCL), multiple myeloma, and other hematological malignancies. It assists in determining disease prognosis and guiding treatment.


How is the test conducted?

A biopsy sample is taken from lymph nodes or bone marrow and processed for immunohistochemical staining. A pathologist examines the stained tissue under a microscope to assess MUM1 protein expression.


What do abnormal results indicate?

Positive staining for MUM1 suggests certain types of B-cell lymphomas or multiple myeloma. It helps differentiate aggressive lymphomas from indolent ones, influencing treatment strategies.


What are the next steps if the test is positive?

If MUM1 expression is detected, further molecular tests or imaging may be needed. Treatment options could include chemotherapy, targeted therapy, or immunotherapy, depending on the type and stage of lymphoma.